Clinical trials for Kidney cancer
106 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT05503797
#2024-513578-23-00
Locally Advanced
Metastatic
BRAF
1
2
3 or more
KRAS G12C
KRAS non G12C
NRAS
HRAS
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Nord de Marseille (Marseille Cedex 20), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest) (and 2 more...)
Fore Biotherapeutics
Phase 2
Kidney cancer
#NCT05096390
#2024-513986-38-00
Papillary carcinoma
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre Antoine Lacassagne (Nice), Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire de Bordeaux (Bordeaux), IUCT Oncopôle (Toulouse), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ) (and 3 more...)
Centre Léon Bérard
Phase 2
Kidney cancer
#NCT04299646
Clear cell carcinoma
Metastatic
1
2
0
1 or 2
Systemic Treatment-Naive
Immunotherapy
Targeted therapy
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre François Baclesse (Caen ), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Institut de Cancérologie de Bourgogne - Site de Dijon (Dijon), Centre de Radiothérapie Marie Curie (Valence) (and 3 more...)
Centre François Baclesse
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06818643
#2024-516817-19-00
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
Centre Eugene Marquis (Rennes), Centre Oscar Lambret (Lille), Gustave Roussy (Villejuif), Institut Paoli-Calmettes (Marseille)
Merck Sharp & Dohme LLC
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06833008
#2024-519184-18-00
Metastatic
BRAF
KRAS G12C
KRAS non G12C
NRAS
HRAS
KRAS G12D
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Hôpital Saint Louis AP-HP (Paris)
Epizyme, Inc. (Ipsen)
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT05356741
HER2 Positive
Locally Advanced
Metastatic
Metastatic Castration-resistant
HER2
1
2
3 or more
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse)
Vir Biotechnology, Inc.
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06898450
Parties A and B (Patients non sélectionnés)
Locally Advanced
Metastatic
Metastatic Castration-resistant
1
2
3 or more
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Hôpital Saint Antoine AP-HP (Paris)
Nimbus Wadjet, Inc.
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
#NCT06796907
#2024-517147-31-00
Modules 3 et 4
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
Centre de Cancérologie du Grand Montpellier (Montpellier), Gustave Roussy (Villejuif), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
GlaxoSmithKline
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06697197
#2024-516602-28-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
1
2
3 or more
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille)
Bristol-Myers Squibb
Phase 1 / Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Bladder / Urinary Tract / Urethral cancer
Stomach and esophageal cancer
Endometrial cancer
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT06622486
#2024-512921-10-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
1
2
3 or more
Immunotherapy
Systemic Treatment-Naive
Institut Curie - Paris (Paris), Institut du cancer de Montpellier (Montpellier)
Egle Therapeutics